维普期刊资源整合服务平台（V6.5）

109篇 您的检索式：作者名="Spiller J"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	Political institutions and electric utility investment:A cross-nation analysis 显示文摘	BERGARA M E HENISZ W J SPILLER P T	1998	California Management Review1998，40，2：	1
2	A second conserved GAF domain cysteine is required for the blue/green photoreversibility of cy- anobacteriochrome TIr0924 from Thermosynecho- coccus elongates 显示文摘	Rockwell N C Njuguna S L Roberts L Castillo E Parson V L Dwojak S Lagarias J C Spiller S C	2008	Biochemistry2008，47，：	1
3	Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome : post survey of patients 显示文摘	Neal KR Hebden J Spiller R	1997	BMJ1997，314，7083：	1
4	Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: post survey of patients显示文摘	Neal KR Hebden J Spiller R	1997	BM J1997，314，7083：	1
5	Irritable bowel syndrome: a little understood organic bowel disease? 显示文摘	Talley N J Spiller R	2010	Lancet2010，360，9332：	1
6	Normal-incidence soft x-ray telescopes 显示文摘	SPILLER E McCORKLE R A WILCZYNSKI J S	1991	Opt Eng1991，30，8：	1
7	Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients显示文摘	NEAL KR HEBDEN J SPILLER R	1997	BMJ1997，314，：	1
8	Pathogenesis of colonic diverticula显示文摘	Simpson J Scholefield JH Spiller RC	2002	Br J Surg2002，89，5：	1
9	Increased rectal mucosal enteroendecrine cells, T lymphecytes, and increased gut permeability following acute Campylobacter enteritis and in post - dysenteric irritable bowel syndrome 显示文摘	Spiller R C Jenkins D Thornley J P	2000	Gut2000，47，：	1
10	Comparative efficacy of once daily, 5-day short-course therapy with clarithromycin extended-release versus twice daily, 7-day therapy with clarithromycin immediate-release in acute bacterial exacerbation of chronic bronchitis显示文摘	Gotfried M Notario G Spiller J	2005	Curr Med Res Opin2005，21，2：	1
11	PPHN:Is sidenafil the new nitric? A review of the literature显示文摘	Spillers J		0，，02：	1
12	Production of yellow color inflowers: redirection of flavonoid biosynthesis in Petunia 显示文摘	Davis K M Bloor S J Spiller G B	1998	Plant J1998，，13：	1
13	Fare determination in airline hub-and-spoke networks显示文摘	Brueckner Jan K N J Dyer P T Spiller	1992	Rand Journal of Economics1992，23，：	1
14	Spontaneous dissectingintramural hematoma of the oesophagus: a rare cause ofhaematemesis and dysphagia显示文摘	SPILLER R C CATTO J V KANE S P	1981	Endoscopy1981，13，：	1
15	TLR4/MD-2 monoclonal antibody therapy affords protection in experimental models of septic shock显示文摘	Daubeuf B Mathison J Spiller S Hugues S Herren S Ferlin W	2007	J Immunol2007，179，：	1
16	Irritable bowel syndrome: a little understood organic bowel disease? 显示文摘	Talley N J Spiller R	2010	Lancet2010，360，9332：	1
17	TLR4/MD-2 mono- clonal antibody therapy affords protection in experimental models of septic shock 显示文摘	Daubeuf B Mathison J Spiller S	2007	J Immunol2007，179，9：	1
18	Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis mid risk factors for development of the irritable bowel syndrome: postal survey of patients显示文摘	Neal K R Hebden J Spiller R C	1997	BMJ1997，314，：	1
19	A, et aL Inhihitinn of nuclearfactor kappa-B signaling reduces growth in m<*dullul)last?ma in ww显示文摘	Spiller S h’ IxtgKflon N J Deckanl I	2011	BMC Cancer2011，，11：	1
20	TLR4/MD - 2 monoclonal antibody therapy affords protection in experimental models of septic shock 显示文摘	Daubeuf B Mathison J Spiller S	2007	J Immunol2007，179，9：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示